Biotechnology

Breakthrough in Gene-Editing Therapy for Cholesterol Reduction Verve Therapeutics has announced encouraging results from its Phase 1b clinical trial of VERVE-102, a gene-editing therapy targeting PCSK9 to lower LDL-C, or …

New Phase 3 Data Highlights Potential for ADC-Keytruda Combination in Lung Cancer Recent clinical data released ahead of the 2026 American Society of Clinical Oncology (ASCO) annual meeting signals a …

Precision Drug Delivery Breakthrough: First-in-Human Trial for Pancreatic Cancer Begins By Dr. Natalie Singh | Health Editor | May 20, 2026 A new era in pancreatic cancer treatment has begun …

TrumpRx Expands: Platform Adds Generic Drugs and New Pharmacy Tools The Trump administration is scaling its direct-to-consumer drug pricing platform, TrumpRx.gov, with a significant expansion of its offerings. On Monday, …

Hydrogel-Based Cell Encapsulation: A Potential Game-Changer for Type 1 Diabetes By Dr. Natalie Singh, Health Editor | May 18, 2026 For the 9.5 million people worldwide living with Type 1 …

U.K. Advocacy Groups Challenge New Pharmaceutical Trade Deal with U.S.: Risks to Medicine Access and Patient Safety By Dr. Natalie Singh | Health Editor | May 18, 2026 Two prominent …

The Evolution of Research: Integrating AI into Modern Workflows The landscape of information gathering is undergoing a fundamental shift. For decades, research meant manual keyword searches, endless scrolling through database …

CDC to Transfer Over 160 Macaques to Texas Sanctuary in Research Phase-Out Effort The Centers for Disease Control and Prevention (CDC) is advancing efforts to reduce the use of primates …

Capricor Therapeutics has initiated legal action against its distribution partners to ensure that patients with Duchenne muscular dystrophy (DMD) can access a potentially life-changing cell therapy. The lawsuit centers on …